How does the gut microbiome influence immune checkpoint blockade therapy?
Immune checkpoint blockade (ICB) therapies are revolutionary cancer treatments; however, they only benefit about a third of patients. Therefore, extensive research is underway to find methods to improve their therapeutic efficacy. One avenue of study that has recently emerged is to consider the role the gut microbiome plays in therapeutic success. Several high-impact studies have repeatedly shown that the presence, composition and level of diversity of the gut flora directly impact cancer...[Show more]
|Collections||ANU Research Publications|
|Source:||Immunology and Cell Biology|
|01_Almonte_How_does_the_gut_microbiome_2020.pdf||2.03 MB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.